Is Chemoradiotherapy Beneficial for Stage IV Rectal Cancer?

Publisher： Karger

E-ISSN： 1423-0232|89|1|14-22

ISSN： 0030-2414

Source： Oncology, Vol.89, Iss.1, 2015-03, pp. : 14-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ALDH1 is a prognostic factor for patients treated with neoadjuvant chemoradiotherapy and radical resection for stage III rectal cancer

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 2, 2015-02 ,pp. : 243-247

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ongoing evolution of preoperative chemoradiotherapy for rectal cancer

By  

ANZ JOURNAL OF SURGERY, Vol. 88, Iss. 1-2, 2018-01 ,pp. : 8-9

John Wiley & Sons Inc

Access to resources Recommend Favorite

Downstage migration after neoadjuvant chemoradiotherapy for rectal cancer: The reverse of the Will Rogers phenomenon?

By  

CANCER, Vol. 121, Iss. 11, 2015-06 ,pp. : 1724-1727

John Wiley & Sons Inc

Access to resources Recommend Favorite

Which Patients Benefit from Preoperative Chemoradiotherapy for Intermediate Staged Rectal Cancer?

By  

Oncology Research and Treatment, Vol. 34, Iss. 1-2, 2011-01 ,pp. : 36-41

Karger

Access to resources Recommend Favorite

Predictive Factors of Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer

By  

Oncology, Vol. 78, Iss. 5-6, 2010-08 ,pp. : 369-375

Karger

Access to resources Recommend Favorite